News
-
HPV is a large viral family with more than 200 identified types, about 30 to 40 of which are associated with genital tract infections. Based on carcinogenic risk, HPV is divided into high-risk and low-risk types. The 14 high-risk types confirmed by the World Health Organization and the International Agency for Research on Cancer include HPV 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68. These are closely linked to the development of cervical cancer and precancerous lesions.Read more -
Nonspecific STI symptoms? Stop guessing. Start multiplexing.
Discharge. Pain. Lesions. Recurrent symptoms. Asymptomatic cases.Read more -
Fully Automated. Fully Enclosed. Designed to Minimize Cross-Contamination Risk.
In molecular diagnostics, reliable results depend not only on accurate detection, but also on a well-controlled testing workflow.Read more -
Respiratory Pathogen Panel PCR: Matching Target Coverage to Seasonal Testing Demand
Fever, cough, sore throat, and shortness of breath can appear across several respiratory infections. For a molecular laboratory, the challenge is not simply whether PCR can detect a pathogen; it is deciding which group of targets should be tested together for the patient population and season the laboratory actually serves.Read more -
MTB and NTM PCR Testing: Building a Practical Molecular Workflow for Respiratory Specimens
Tuberculosis PCR is sometimes discussed as if amplification were the whole workflow. In reality, sputum and bronchial samples are challenging matrices. Collection quality, liquefaction or preprocessing, nucleic-acid extraction, internal controls, and contamination management all influence the reliability of the final molecular result.Read more -
Molecular POCT Beyond the Central Lab: Planning a Practical NATBox PCR Workflow
PCR used to imply a central laboratory, multiple work areas, separate extraction and amplification steps, and a team comfortable with molecular workflows.Read more -
HPV Genotyping in Routine PCR: Choosing Coverage, Specimen Type, and Workflow
HPV molecular testing becomes more informative when the assay design matches the purpose of the screening or diagnostic workflow. Some programs need detection of high-risk HPV with limited genotype differentiation. Others want broader genotype information because the laboratory or clinical pathway uses more detailed risk stratification.Read more -
Enterovirus, EV71 and CoxA16 PCR: A Focused Approach for Gastrointestinal and HFMD Testing
Diarrhea, vomiting, fever, and abdominal discomfort can be caused by different pathogens, and symptoms alone may not identify the responsible agent. Molecular testing gives laboratories a way to ask a more focused question when the clinical or epidemiological context points toward a defined group of targets.Read more -
Dengue, Zika and Chikungunya PCR: Why Multiplex Testing Matters in Arbovirus Workflows
Dengue, Zika, and chikungunya are distinct viral infections, but they can overlap in geography, vector ecology, and early clinical presentation. In areas where Aedes mosquitoes circulate, fever, rash, headache, and joint symptoms may not point to one pathogen with enough certainty for a single-target assumption.Read more -
When the Clinical Picture Is Not Specific, Should Testing Be?
STIs do not always present with a clear clinical signature.Read more -
TB Diagnosis Is Moving Closer to the Point of Care
Tuberculosis remains a major global diagnostic challenge. In 2024, an estimated 10.7 million people developed TB, and 1.23 million died from the disease.Read more -
WHO recognizes around 200 known HPV types, with different types associated with different clinical outcomes. In most people, HPV infection is controlled naturally—but persistent infection with certain high-risk types is the key concern in cervical cancer.Read more
